http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101495275-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-563 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-563 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2013-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101495275-B1 |
| titleOfInvention | Target protein for both diagnosis and treatment of lung cancer |
| abstract | The present invention relates to a composition for diagnosing or treating lung cancer, which comprises an active ingredient that specifically binds to a novel lung cancer target protein. The present invention relates to a composition for diagnosing or treating lung cancer, which comprises APOO (Apolipoprotein O), ATP1A1 (ATPase, Na + / K + transporting, , Canxin (calnexin), and dolichyl-diphosphooligosaccharide-protein glycosyltransferase (DDOST) as an active ingredient. The present invention also provides a composition for diagnosing or treating lung cancer, which comprises a substance that specifically binds to a target polypeptide selected from the group consisting of: Since the target polypeptide is specifically overexpressed in lung cancer tissues or cells, it is not only suitable as a target substance for diagnosis or treatment of lung cancer but also can be easily detected by a non-invasive method since it is a membrane protein expressed on the surface of cells, Can be usefully used as a target substance for the diagnosis and treatment of lung cancer. |
| priorityDate | 2012-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 650.